Mark Schoenberg
2020
Compensation breakdown
| Non-Equity Incentive Plan | $293,150 |
|---|---|
| Option Awards | $292,054 |
| Salary | $185,026 |
| Stock Awards | $176,460 |
| Other | $1,767 |
| Total | $948,458 |
Schoenberg received $293.2K in non-equity incentive plan, accounting for 31% of the total pay in 2020.
Schoenberg also received $292.1K in option awards, $185K in salary, $176.5K in stock awards and $1.8K in other compensation.
Rankings
In 2020, Mark Schoenberg's compensation ranked 8,856th out of 13,090 executives tracked by ExecPay. In other words, Schoenberg earned more than 32.3% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 8,856 out of 13,090 | 32nd |
Division Manufacturing | 3,780 out of 5,618 | 33rd |
Major group Chemicals And Allied Products | 1,530 out of 2,251 | 32nd |
Industry group Drugs | 1,333 out of 1,951 | 32nd |
Industry Pharmaceutical Preparations | 987 out of 1,456 | 32nd |
Pay ratio
| Mark Schoenberg's Pay | $948,458 |
|---|---|
| Median Employee's Pay | $222,109 |
| Pay Ratio | 4to 1 |
In 2020, the annual total compensation of Mark Schoenberg was $948,458.
The annual total compensation of the median employee at UroGen Pharma Ltd. was $222,109.
The ratio of Mark Schoenberg's pay to the pay of median employee was therefore 4 to one.
Schoenberg's colleagues
We found five more compensation records of executives who worked with Mark Schoenberg at UroGen Pharma Ltd. in 2020.
2020
Elizabeth Barrett
UroGen Pharma Ltd.
Chief Executive Officer
2020
Jason Smith
UroGen Pharma Ltd.
General Counsel
2020
Molly Henderson
UroGen Pharma Ltd.
Chief Financial Officer
2020
Peter Pfreundschuh
UroGen Pharma Ltd.
Chief Financial Officer
2020
Stephen Mullennix
UroGen Pharma Ltd.